Skip to main content
. 2023 Jul 12;15(14):3592. doi: 10.3390/cancers15143592

Figure 3.

Figure 3

Linear regression for CD3CD56+ NK cells and progression-free survival (PFS) (linear R2 = 0.191) and overall survival (OS) (linear R2 = 0.250).